Related references
Note: Only part of the references are listed.Isoform and tissue dependent impact of apolipoprotein E on adipose tissue metabolic activation: The role of apolipoprotein A1
Christina Kalogeropoulou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2020)
Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-Alpha
Emma Morris et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
Nina Shah et al.
LEUKEMIA (2020)
Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy
Shiny Nair et al.
MOLECULAR GENETICS AND METABOLISM (2020)
Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
Patricia Dubot et al.
CANCERS (2020)
Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia
Jianai Sun et al.
FRONTIERS IN ONCOLOGY (2020)
Exosomes in the Pathogenesis and Treatment of Multiple Myeloma in the Context of the Bone Marrow Microenvironment
Tianzeng Chen et al.
FRONTIERS IN ONCOLOGY (2020)
Pharmacological Management of Dyslipidemia in Atherosclerosis: Limitations, Challenges, and New Therapeutic Opportunities
Kyriakos E. Kypreos et al.
ANGIOLOGY (2019)
Impact of apolipoprotein A1 or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice
Eva Xepapadaki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Lipid metabolism in cancer cells under metabolic stress
Rimsha Munir et al.
BRITISH JOURNAL OF CANCER (2019)
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease
Huan Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone
Timothy M. Schmidt et al.
BLOOD CANCER JOURNAL (2019)
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Konstantinos Avgerinos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
The obese adipose tissue microenvironment in cancer development and progression
Daniela F. Quail et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma
Danielle Harmer et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Multiple Myeloma and Fatty Acid Metabolism
Majdi Masarwi et al.
JBMR PLUS (2019)
Molecular Players in Hematologic Tumor Cell Trafficking
Javier Redondo-Munoz et al.
FRONTIERS IN IMMUNOLOGY (2019)
Identification of High Serum Apolipoprotein A1 as a Favorable Prognostic Indicator in Patients with Multiple Myeloma
Lifan Liang et al.
JOURNAL OF CANCER (2019)
Site-specific effects of apolipoprotein E expression on diet-induced obesity and white adipose tissue metabolic activation
Aikaterini Hatziri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention
Alessandro Allegra et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Phase I study of the heparanase inhibitor roneparstat: an innovative approach for multiple myeloma therapy
Monica Galli et al.
HAEMATOLOGICA (2018)
Pathogenesis of bone disease in multiple myeloma: from bench to bedside
Evangelos Terpos et al.
BLOOD CANCER JOURNAL (2018)
Phase I study of the heparanase inhibitor roneparstat: an innovative approach for multiple myeloma therapy
Monica Galli et al.
HAEMATOLOGICA (2018)
Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
Sylvia Faict et al.
BLOOD CANCER JOURNAL (2018)
High-density lipoprotein (HDL) metabolism and bone mass
Nicholaos I. Papachristou et al.
JOURNAL OF ENDOCRINOLOGY (2017)
Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity
Evangelia Zvintzou et al.
JOURNAL OF LIPID RESEARCH (2017)
Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
Caterina Musolino et al.
MEDIATORS OF INFLAMMATION (2017)
The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma
Caleb K. Stein et al.
ONCOTARGET (2017)
Adiposity and cancer at major anatomical sites: umbrella review of the literature
Maria Kyrgiou et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Adiposity and cancer at major anatomical sites: umbrella review of the literature
Maria Kyrgiou et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Vital Signs: Trends in Incidence of Cancers Associated with Overweight and Obesity — United States, 2005–2014
C. Brooke Steele et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
PATHOBIOLOGY AND DIAGNOSIS OF MULTIPLE MYELOMA
Kevin Brigle et al.
SEMINARS IN ONCOLOGY NURSING (2017)
Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study
Marianna Thordardottir et al.
BLOOD ADVANCES (2017)
Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia
Xavier Cahu et al.
BLOOD ADVANCES (2017)
Light Chain Myeloma induced Severe Hypertriglyceridemia
Shafeeque Rahman et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2017)
Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment
Manar S. Shafat et al.
BLOOD (2017)
Myeloma today: Disease definitions and treatment advances
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone
Timothy N. Trotter et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Advances in high-density lipoprotein physiology: surprises, overturns, and promises
Caterina Constantinou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function
Serafoula Filou et al.
BIOCHEMISTRY (2016)
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment
Yu-Tzu Tai et al.
BLOOD (2016)
Adipocytes contribute to the growth and progression of multiple myeloma: Unraveling obesity related differences in adipocyte signaling
Erica M. Bullwinkle et al.
CANCER LETTERS (2016)
Metastasis Stimulation by Hypoxia and Acidosis-Induced Extracellular Lipid Uptake Is Mediated by Proteoglycan-Dependent Endocytosis
Julien A. Menard et al.
CANCER RESEARCH (2016)
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Meletios A. Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Statins Are Associated With Reduced Mortality in Multiple Myeloma
Kristen Marie Sanfilippo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma
Shiny Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cyclin D1 unbalances the redox status controlling cell adhesion, migration, and drug resistance in myeloma cells
Sophie Bustany et al.
ONCOTARGET (2016)
Scavenger Receptor Class B Type I Regulates Plasma Apolipoprotein E Levels and Dietary Lipid Deposition to the Liver
Eleni A. Karavia et al.
BIOCHEMISTRY (2015)
Revisiting the dyslipidemia associated with acute leukemia
Hina Usman et al.
CLINICA CHIMICA ACTA (2015)
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
Antonio Palumbo et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A Comparison of Methods To Enhance Protein Detection of Lipoproteins by Mass Spectrometry
Anna Heink et al.
JOURNAL OF PROTEOME RESEARCH (2015)
PUFAs: Structures, Metabolism and Functions
Anna Wiktorowska-Owczarek et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2015)
Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation
Zhiqiang Liu et al.
ONCOTARGET (2015)
Diet-induced obesity promotes a myeloma-like condition in vivo
S. T. Lwin et al.
LEUKEMIA (2015)
Atypical plasma lipid profile in cancer patients: Cause or consequence?
Rimsha Munir et al.
BIOCHIMIE (2014)
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1
Tomohiro Umezu et al.
BLOOD (2014)
Effects of bariatric surgery on HDL structure and functionality: results from a prospective trial
Evangelia Zvintzou et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
The role of heparanase and sulfatases in the modification of heparan sulfate proteoglycans within the tumor microenvironment and opportunities for novel cancer therapeutics
Edward Hammond et al.
FRONTIERS IN ONCOLOGY (2014)
HDL quality and functionality: what can proteins and genes predict?
Eleni A. Karavia et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2014)
Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature
Maarten Arends et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression
Aldo M. Roccaro et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Induction of apoptosis in multiple myeloma cells by a statin-thalidomide combination can be enhanced by p38 MAPK inhibition
Adrianna Slawinska-Brych et al.
LEUKEMIA RESEARCH (2013)
Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet
I. -E. Triantaphyllidou et al.
OSTEOARTHRITIS AND CARTILAGE (2013)
Low-density lipoprotein cholesterol suppresses apoptosis in human multiple myeloma cells
Jose Manuel Tirado-Velez et al.
ANNALS OF HEMATOLOGY (2012)
Qualitative characteristics of HDL in young patients of an acute myocardial infarction
Anthula E. Kavo et al.
ATHEROSCLEROSIS (2012)
Apolipoprotein A-I Modulates Processes Associated with Diet-Induced Nonalcoholic Fatty Liver Disease in Mice
Eleni A. Karavia et al.
MOLECULAR MEDICINE (2012)
Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
Marek Hus et al.
ANNALS OF HEMATOLOGY (2011)
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Dimitri P. Mikhailidis et al.
Current Vascular Pharmacology (2011)
“European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary
Dimitri P. Mikhailidis et al.
Current Vascular Pharmacology (2011)
Body mass index and risk of multiple myeloma: A meta-analysis of prospective studies
Alice Wallin et al.
EUROPEAN JOURNAL OF CANCER (2011)
Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice
Eleni A. Karavia et al.
FEBS JOURNAL (2011)
N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation
Richard W. J. Groen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Hyperlipidemic myeloma: review of 53 cases
Benjamin Misselwitz et al.
ANNALS OF HEMATOLOGY (2010)
HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis
Eirini M. Tsompanidi et al.
ATHEROSCLEROSIS (2010)
Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma
Rogier M. Reijmers et al.
BLOOD (2010)
The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients
Tamar H. Taddei et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop
Jerome Moreaux et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma
T. E. Sondergaard et al.
HEMATOLOGICAL ONCOLOGY (2009)
Syndecan-1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumors in Vivo
Yekaterina B. Khotskaya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice
Kristin I. Stanford et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: A case report
C. Martinez-Redondo et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Serum lipoproteins and cancer
S. Muntoni et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2009)
Cholesterol levels in patients with multiple myeloma
Irfan Yavasoglu et al.
ANNALS OF HEMATOLOGY (2008)
Lipid changes occuring in the course of hematological cancers
Malgorzata Kuliszkiewicz-Janus et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2008)
Defective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient mice
Susanna M. Hofmann et al.
DIABETES (2008)
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy
Yang Yang et al.
BLOOD (2007)
Increase in fluidity in the membrane of MT3 breast cancer cells correlates with enhanced cell adhesion in vitro and increased lung metastasis in NOD/SCID mice
Reiner Zeisig et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members
Jennifer M. MacArthur et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma
W. Wei-Lynn Wong et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Endogenous ApoE expression modulates adipocyte triglyceride content and turnover
Zhi Hua Huang et al.
DIABETES (2006)
Biophysical properties of lipids and dynamic membranes
P. A. Janmey et al.
TRENDS IN CELL BIOLOGY (2006)
LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice
KE Kypreos et al.
JOURNAL OF LIPID RESEARCH (2006)
Molecular pathogenesis and a consequent classification of multiple myeloma
PL Bergsagel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
PWB Derksen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Impact of cholesterol on voids in phospholipid membranes
E Falck et al.
JOURNAL OF CHEMICAL PHYSICS (2004)
VLDL induces adipocyte differentiation in ApoE-dependent manner
T Chiba et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Effects of membrane lipids on ion channel structure and function
TS Tillman et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2003)
Lipids as a target for drugs modulating multidrug resistance of cancer cells
AB Hendrich et al.
CURRENT DRUG TARGETS (2003)
Soluble syndecan-1 promotes growth of myeloma tumors in vivo
Y Yang et al.
BLOOD (2002)
The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells
NWCJ van de Donk et al.
LEUKEMIA (2002)
Cell membrane fluidity and prognosis of lung cancer
M Sok et al.
ANNALS OF THORACIC SURGERY (2002)
Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma
PWB Derksen et al.
BLOOD (2002)
Lipid rafts and little caves - Compartmentalized signalling in membrane microdomains
LD Zajchowski et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinorna MCF-7/adr cells
LW Fu et al.
EUROPEAN JOURNAL OF CANCER (2002)
New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E
CP Libeu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The effect of osmotic pressure on the membrane fluidity of Saccharomyces cerevisiae at different physiological temperatures
C Laroche et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2001)
Changes in essential fatty acid patterns associated with normal liver regeneration and the progression of hepatocyte nodules in rat hepatocarcinogenesis
S Abel et al.
CARCINOGENESIS (2001)
Reversal of multidrug resistance and increase in plasma membrane fluidity in CHO cells with R-verapamil and bile salts
H Schuldes et al.
EUROPEAN JOURNAL OF CANCER (2001)
Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice
X Lin et al.
DEVELOPMENTAL BIOLOGY (2000)
The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromes
K Allampallam et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2000)
Share Paper
